Literature DB >> 21730964

Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat.

B Gaborit1, F Kober, A Jacquier, P J Moro, T Cuisset, S Boullu, F Dadoun, M-C Alessi, P Morange, K Clément, M Bernard, A Dutour.   

Abstract

OBJECTIVE: To assess epicardial fat volume (EFV), myocardial TG content (MTGC) and metabolic profile in severely obese patients, and to determine whether ectopic fat depots are linked to metabolic disorders or myocardial function. RESEARCH DESIGN AND METHODS: Sixty-three subjects with normal LV function and no coronary artery disease, including 33 lean (BMI: 21.4 ± 2.0 kg m(-2)) and 30 obese (BMI: 41.8 ± 6 kg m(-2)) patients, underwent 3-T cardiovascular MRI, and anthropometric, biological and visceral abdominal fat (VAT) assessments. EFV was measured by short-axis slice imaging and myocardial (intra-myocellular) TG content was measured by proton magnetic resonance spectroscopy.
RESULTS: EFV and MTGC were positively correlated (r=0.52, P<0.0001), and were both strongly correlated with age, BMI, waist circumference and VAT, but not with severity of obesity. EFV and MTGC were significantly higher in obese patients than in lean controls (141 ± 18 versus 79 ± 7 ml, P=0.0001; 1.0 ± 0.1 versus 0.6 ± 0.1%, P=0.01, respectively), but some differences were found between the two cardiac depots: EFV was higher in diabetic obese subjects as compared with that in non-diabetic obese subjects (213 ± 34 versus 141 ± 18 ml, P=0.03), and was correlated with parameters of glucose tolerance (fasting plasma glucose, insulin and HOMA-IR), whereas MTGC was not. EFV and MTGC were both associated with parameters of lipid profile or inflammation (TGs, CRP). Remarkably, this was VAT-dependent, as only VAT remained independently associated with metabolic parameters (P<0.01). Concerning myocardial function, MTGC was the only parameter independently associated with stroke volume (β=-0.38, P=0.01), suggesting an impact of cardiac steatosis in cardiac function.
CONCLUSIONS: These data show that VAT dominates the relationship between EFV, MTGC and metabolic measures, and uncover specific partitioning of cardiac ectopic lipid deposition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21730964     DOI: 10.1038/ijo.2011.117

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  29 in total

1.  Myocardial steatosis and its association with obesity and regional ventricular dysfunction: evaluated by magnetic resonance tagging and 1H spectroscopy in healthy African Americans.

Authors:  Chia-Ying Liu; David A Bluemke; Gary Gerstenblith; Stefan L Zimmerman; Ji Li; Hong Zhu; Shenghan Lai; Hong Lai
Journal:  Int J Cardiol       Date:  2014-01-24       Impact factor: 4.164

2.  Resistance exercise improves cardiac function and mitochondrial efficiency in diabetic rat hearts.

Authors:  Tae Hee Ko; Jubert C Marquez; Hyoung Kyu Kim; Seung Hun Jeong; SungRyul Lee; Jae Boum Youm; In Sung Song; Dae Yun Seo; Hye Jin Kim; Du Nam Won; Kyoung Im Cho; Mun Gi Choi; Byoung Doo Rhee; Kyung Soo Ko; Nari Kim; Jong Chul Won; Jin Han
Journal:  Pflugers Arch       Date:  2017-10-14       Impact factor: 3.657

3.  Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss.

Authors:  B Gaborit; I Abdesselam; F Kober; A Jacquier; O Ronsin; O Emungania; N Lesavre; M-C Alessi; J C Martin; M Bernard; A Dutour
Journal:  Int J Obes (Lond)       Date:  2014-07-21       Impact factor: 5.095

4.  Abnormal Myocardial Function Is Related to Myocardial Steatosis and Diffuse Myocardial Fibrosis in HIV-Infected Adults.

Authors:  Diana K Thiara; Chia Ying Liu; Fabio Raman; Sabrina Mangat; Julia B Purdy; Horacio A Duarte; Nancyanne Schmidt; Jamie Hur; Christopher T Sibley; David A Bluemke; Colleen Hadigan
Journal:  J Infect Dis       Date:  2015-05-11       Impact factor: 5.226

5.  Myocardial Fat Accumulation Is Independent of Measures of Insulin Sensitivity.

Authors:  Ranganath Muniyappa; Radwa Noureldin; Ronald Ouwerkerk; Elizabeth Y Liu; Ritu Madan; Brent S Abel; Katherine Mullins; Mary F Walter; Monica C Skarulis; Ahmed M Gharib
Journal:  J Clin Endocrinol Metab       Date:  2015-05-28       Impact factor: 5.958

6.  CEST MRI reveals a correlation between visceral fat mass and reduced myocardial creatine in obese individuals despite preserved ventricular structure and function.

Authors:  Wissam AlGhuraibawi; Tori Stromp; Rebecca Holtkamp; Bonnie Lam; Wolfgang Rehwald; Steve W Leung; Moriel Vandsburger
Journal:  NMR Biomed       Date:  2019-05-15       Impact factor: 4.044

Review 7.  Impact of obesity and bariatric surgery on metabolism and coronary circulatory function.

Authors:  Ines Valenta; Vasken Dilsizian; Alessandra Quercioli; Freimut D Jüngling; Giuseppe Ambrosio; Richard Wahl; Thomas H Schindler
Journal:  Curr Cardiol Rep       Date:  2014-01       Impact factor: 2.931

8.  Measurements of pericardial adipose tissue using contrast enhanced cardiac multidetector computed tomography--comparison with cardiac magnetic resonance imaging.

Authors:  Marie Bayer Elming; Jacob Lønborg; Thomas Rasmussen; Jørgen Tobias Kühl; Thomas Engstrøm; Niels Vejlstrup; Lars Køber; Klaus F Kofoed
Journal:  Int J Cardiovasc Imaging       Date:  2013-05-24       Impact factor: 2.357

9.  Association of serum hepatocyte growth factor with pericardial fat volume in patients with coronary artery disease.

Authors:  Jingning Liu; Zhengxia Liu; Shikun Cai; Peng Lu; Xiang Lu; Gang Peng
Journal:  Int J Clin Exp Med       Date:  2015-05-15

10.  Effects of age and aerobic fitness on myocardial lipid content.

Authors:  Satyam Sarma; Graeme Carrick-Ranson; Naoki Fujimoto; Beverley Adams-Huet; Paul S Bhella; Jeffrey L Hastings; Keri M Shafer; Shigeki Shibata; Kara Boyd; Dean Palmer; Edward W Szczepaniak; Lidia S Szczepaniak; Benjamin D Levine
Journal:  Circ Cardiovasc Imaging       Date:  2013-09-13       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.